INTELLIGENT BIO SOLUTIONS INC. Convertible Debt, Current
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Convertible Debt, Current of $5.13 million as of 2020-06-30, per its 10-K filed 2021-09-16.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt and Lease Obligation, Current
us-gaap:ConvertibleDebtCurrent · last filed 2021-09-16
- 2020-06-30: Convertible Debt, Current $5.13M.
| Period end | Convertible Debt, Current |
|---|---|
| 2020-06-30 | $5.13M 10-K · filed 2021-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |